data_1prr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1prr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' H3 ' ' HE1' ' A' ' 1' ' ' MET . 26.2 mmt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.818 0.342 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.43 172.86 14.26 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.992 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 1.6 p30 179.96 123.71 0.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.72 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 pt -74.49 141.28 16.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.334 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 m -120.25 112.85 19.57 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.2 174.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.557 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 1.106 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 48.5 m-85 -133.91 147.1 51.06 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.19 -37.5 61.16 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.51 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 35.3 m120 -107.54 162.72 13.69 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.639 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.3 mt-10 -72.07 169.51 15.87 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.577 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 13' ' ' GLN . 1.5 t0 70.97 34.02 1.98 Allowed 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 60.5 -2.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.504 ' CG ' ' H ' ' A' ' 14' ' ' GLY . 8.4 tt0 -88.53 174.51 8.05 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.51 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 91.06 137.4 7.25 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' GLY . 2.7 mttp -33.29 143.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.641 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 1.106 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.55 168.86 9.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.44 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.86 132.59 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.398 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -93.7 125.96 38.6 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.239 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mt -121.38 126.95 26.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.333 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 158.62 45.63 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.938 1.092 . . . . 0.0 111.017 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.65 -167.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.739 1.626 . . . . 0.0 111.309 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 96.49 173.85 35.38 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.78 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -106.3 128.6 54.1 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.834 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 5.2 p90 -146.38 177.45 9.01 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.461 HG21 ' CZ ' ' A' ' 58' ' ' PHE . 6.4 p -139.93 -160.95 1.13 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.2 -20.53 59.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.63 -63.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.776 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -56.26 -45.03 80.24 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.674 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -56.22 -41.44 75.65 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.826 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.21 53.54 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.942 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.53 -38.04 83.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.935 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.8 mt -75.11 -73.29 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.451 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.51 -35.24 0.51 Allowed Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 tt -80.44 142.57 13.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.051 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.22 165.62 9.0 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.686 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.0 m120 62.87 -137.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 123.608 0.567 . . . . 0.0 111.602 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.832 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -80.38 98.48 7.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.702 -0.799 . . . . 0.0 113.012 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.473 ' C ' ' H ' ' A' ' 40' ' ' SER . 3.4 p -154.69 -24.54 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.474 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' SER . 60.5 mt -78.11 44.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.386 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.473 ' H ' ' C ' ' A' ' 38' ' ' THR . 19.5 t -38.48 -50.55 1.55 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.535 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.404 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.2 175.85 6.43 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.433 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.448 HG13 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -152.08 144.7 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.453 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -132.91 95.37 3.55 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.022 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 t -116.92 110.76 41.46 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.59 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -70.67 168.61 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.204 1.269 . . . . 0.0 110.938 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.74 -178.38 0.39 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.055 1.837 . . . . 0.0 111.243 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.64 -21.22 9.43 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.252 -1.451 . . . . 0.0 110.995 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.93 133.53 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.446 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -102.44 136.93 41.38 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.906 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.09 150.38 34.13 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.979 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.05 114.35 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 mp -90.01 155.75 18.88 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.492 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.474 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 27.4 m-85 -138.08 112.02 8.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -45.99 -84.55 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.512 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.92 146.03 43.75 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.038 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -177.16 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.627 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' C ' ' CD2' ' A' ' 58' ' ' PHE . . . 57.01 27.24 56.9 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.354 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.461 ' CZ ' HG21 ' A' ' 25' ' ' THR . 2.7 m-85 56.52 57.34 4.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.94 179.08 6.59 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.031 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.64 175.68 35.12 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.283 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 125.02 4.03 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.523 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -109.1 150.72 27.41 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.521 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.504 HG21 ' H ' ' A' ' 64' ' ' GLU . 2.0 mt -125.08 163.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' H ' HG21 ' A' ' 63' ' ' ILE . 34.1 mt-10 -141.91 131.39 23.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.728 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.57 162.69 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.572 ' H ' ' HH ' ' A' ' 121' ' ' TYR . 3.0 t -141.12 -12.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.595 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -117.74 -156.66 0.64 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.477 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.53 HD22 ' H ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -93.7 116.29 28.77 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.019 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.448 ' H ' HG13 ' A' ' 42' ' ' VAL . . . -89.49 116.11 27.42 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -73.8 -75.76 0.14 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.663 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -9.87 59.18 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.538 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 73' ' ' GLY . 4.6 tp 66.74 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.385 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.448 ' H ' ' HB3' ' A' ' 72' ' ' LEU . . . 175.5 -178.45 47.1 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.44 -35.04 11.3 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.214 1.943 . . . . 0.0 112.219 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.564 ' CD2' ' H ' ' A' ' 75' ' ' LEU . 1.7 pt? -77.54 15.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.225 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -65.93 -2.34 3.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' LEU . 4.4 t-20 -84.9 4.11 34.93 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.106 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.471 HD21 ' N ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -170.32 122.43 0.65 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.153 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.471 ' N ' HD21 ' A' ' 78' ' ' ASN . 1.5 t -147.34 160.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.27 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.427 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.41 ' HG ' HG23 ' A' ' 25' ' ' THR . 3.5 m -101.61 138.51 38.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.386 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.12 160.37 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.453 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.857 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.16 119.23 6.72 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.857 ' H ' HH22 ' A' ' 83' ' ' ARG . 4.0 t -123.67 137.59 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.526 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.559 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.7 mt -135.11 128.95 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.534 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.79 136.42 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.299 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.46 148.78 70.21 Favored Pre-proline 0 N--CA 1.488 1.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.782 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -54.54 139.84 75.33 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.401 1.401 . . . . 0.0 111.44 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 133.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.491 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -137.6 153.32 74.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.437 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 1.2 Cg_endo -59.36 -162.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.927 1.085 . . . . 0.0 110.597 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.514 ' N ' HD13 ' A' ' 136' ' ' LEU . 2.2 ptt180 -177.57 -161.64 0.06 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.583 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.476 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -135.03 176.04 9.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.924 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.607 ' NE ' ' OE1' ' A' ' 105' ' ' GLU . 5.8 ttm180 -147.12 128.08 14.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.361 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 9.1 m-85 -116.24 133.17 56.32 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.33 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.508 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -90.15 -179.23 5.61 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.54 -80.77 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 4.9 mtpt -59.74 149.8 29.81 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.266 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.594 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 79.5 tt0 -69.67 94.8 0.82 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.793 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.4 OUTLIER 134.19 49.73 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.102 1.501 . . . . 0.0 108.506 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' HE1' ' OE1' ' A' ' 100' ' ' GLN . 10.8 p90 32.25 32.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.563 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' GLN . 28.7 t0 -110.49 38.44 2.46 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 104' ' ' LYS . . . -154.6 151.26 22.94 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.185 -1.484 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.532 ' NZ ' ' CE2' ' A' ' 12' ' ' PHE . 4.5 mttm -32.95 139.75 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.347 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE1' ' NE ' ' A' ' 94' ' ' ARG . 2.1 pt-20 -104.44 159.99 15.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.269 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.12 133.99 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.151 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.53 ' H ' HD22 ' A' ' 68' ' ' ASN . 45.1 p-10 -103.15 155.42 18.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.8 mt -145.77 122.35 5.95 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.52 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.18 166.82 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.41 1.407 . . . . 0.0 111.674 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.97 150.82 61.71 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.116 1.877 . . . . 0.0 111.882 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.53 -175.68 20.34 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.63 -1.272 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.548 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.1 tt0 -109.29 156.39 20.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.334 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.6 m-85 -143.37 152.25 41.39 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.775 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.62 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -93.04 -148.79 0.25 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.879 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.62 ' N ' ' OG1' ' A' ' 114' ' ' THR . 6.2 tt0 -108.49 -2.81 18.67 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.61 -62.47 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.975 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.535 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 7.5 pt-20 -66.98 -51.85 50.05 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.715 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.56 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -34.49 -70.74 0.07 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.925 0.766 . . . . 0.0 110.804 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -49.05 -61.51 2.03 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 2.5 mpt_? -75.79 20.7 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.13 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.572 ' HH ' ' H ' ' A' ' 66' ' ' VAL . 12.9 t80 -121.97 -15.61 7.77 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.499 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -149.73 -41.18 0.03 OUTLIER Glycine 0 N--CA 1.484 1.871 0 C-N-CA 118.75 -1.69 . . . . 0.0 110.792 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.15 -106.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.781 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.437 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 3.4 t70 -172.36 -158.78 0.12 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 126' ' ' ASN . 2.0 m-20 -115.8 117.85 31.37 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.418 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 173.97 -0.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.7 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.491 ' O ' ' CB ' ' A' ' 129' ' ' SER . 7.4 mt -67.95 -82.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.804 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 76.35 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.866 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.5 m -38.54 128.98 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.112 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t -120.97 158.73 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.477 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -157.98 97.62 1.87 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.007 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.59 123.04 10.3 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 120.898 1.066 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.476 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -81.29 -1.71 46.16 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.091 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.23 -46.74 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.065 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -99.15 178.81 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.82 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.32 137.98 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.956 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 139' ' ' VAL . 42.3 t -101.12 145.39 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.984 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.457 ' N ' HG11 ' A' ' 138' ' ' VAL . 89.9 t -134.13 121.23 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 140' ' ' LEU . 11.2 mp -99.91 140.32 34.31 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.958 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.465 ' CG ' ' HA ' ' A' ' 146' ' ' PHE . 25.1 m-85 -118.63 128.88 54.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.663 ' CE ' HD22 ' A' ' 164' ' ' ASN . 9.5 tttm -63.03 -76.99 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.161 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.405 ' H ' ' HB3' ' A' ' 142' ' ' LYS . 0.2 OUTLIER -56.92 -178.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.044 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 146' ' ' PHE . 7.6 m-20 -64.47 -144.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.586 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 0.1 OUTLIER -13.37 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 124.574 1.171 . . . . 0.0 113.518 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.5 OUTLIER 31.76 64.5 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.969 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 t -135.42 174.59 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.64 -163.45 53.36 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.28 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.75 165.3 3.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.434 ' HG1' ' HD3' ' A' ' 152' ' ' PRO . 19.2 p -148.0 156.45 42.66 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.599 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.5 tt -125.8 78.92 68.98 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.753 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HD3' ' HG1' ' A' ' 150' ' ' THR . 6.2 Cg_exo -61.58 103.26 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.985 1.79 . . . . 0.0 112.505 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.0 83.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 19.99 1.82 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.646 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 10.7 t -170.39 -178.12 2.63 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.683 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.63 ' N ' ' OG ' ' A' ' 155' ' ' SER . 44.2 m-20 -60.83 145.19 50.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 159' ' ' THR . . . -157.21 63.99 3.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.071 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -65.56 23.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.155 1.903 . . . . 0.0 112.434 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.0 96.57 0.28 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.842 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 161' ' ' GLY . 1.2 mt -123.79 -53.62 1.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.335 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . 35.88 -120.0 0.49 Allowed Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.14 101.07 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.611 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -142.08 -68.38 0.37 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.677 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.714 ' C ' HD21 ' A' ' 164' ' ' ASN . 0.2 OUTLIER -91.34 -108.45 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.573 ' N ' ' ND2' ' A' ' 164' ' ' ASN . 1.8 m120 -153.63 -43.25 0.09 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -179.16 95.42 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.647 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.2 m -50.29 116.68 1.98 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 15.0 m -95.84 -61.97 1.36 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.8 161.3 18.38 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.419 HG12 ' CD1' ' A' ' 118' ' ' LEU . 34.7 pt -144.79 174.64 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.177 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -158.69 112.62 2.43 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.024 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 11.6 mt -88.36 103.41 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.773 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.818 0.342 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.596 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -149.43 172.86 14.26 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.992 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 1.6 p30 179.96 123.71 0.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.72 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 HG22 ' A' ' 44' ' ' VAL . 6.7 pt -74.49 141.28 16.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 m -120.25 112.85 19.57 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.781 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.5 m -91.2 174.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.557 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.964 ' CE2' ' OE1' ' A' ' 16' ' ' GLN . 48.5 m-85 -133.91 147.1 51.06 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.19 -37.5 61.16 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.567 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 35.3 m120 -107.54 162.72 13.69 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.639 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.3 mt-10 -72.07 169.51 15.87 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.577 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.5 t0 70.97 34.02 1.98 Allowed 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 60.5 -2.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 14' ' ' GLY . 51.8 tt0 -88.53 174.51 8.05 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 91.06 137.4 7.25 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' GLY . 2.7 mttp -33.29 143.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.641 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.964 ' OE1' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.55 168.86 9.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.44 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.86 132.59 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.398 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -93.7 125.96 38.6 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.239 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mt -121.38 126.95 26.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.333 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 158.62 45.63 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.938 1.092 . . . . 0.0 111.017 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.65 -167.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.739 1.626 . . . . 0.0 111.309 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 96.49 173.85 35.38 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.78 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.706 ' CA ' HH21 ' A' ' 83' ' ' ARG . 16.6 p-10 -106.3 128.6 54.1 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.834 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 24' ' ' TYR . 5.2 p90 -146.38 177.45 9.01 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 6.4 p -139.93 -160.95 1.13 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.2 -20.53 59.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.63 -63.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.776 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.4 tp60 -56.26 -45.03 80.24 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.674 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.778 HD22 HG23 ' A' ' 34' ' ' ILE . 12.4 mt -56.22 -41.44 75.65 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.826 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.21 53.54 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.942 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.53 -38.04 83.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.935 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 29' ' ' LEU . 8.8 mt -75.11 -73.29 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.451 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.51 -35.24 0.51 Allowed Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.778 HG23 HD22 ' A' ' 29' ' ' LEU . 1.7 tt -80.44 142.57 13.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.22 165.62 9.0 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.686 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.0 m120 62.87 -137.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 123.608 0.567 . . . . 0.0 111.602 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' C ' ' CG2' ' A' ' 38' ' ' THR . 25.3 p-10 -80.38 98.48 7.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.702 -0.799 . . . . 0.0 113.012 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 40' ' ' SER . 3.4 p -154.69 -24.54 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.474 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 6' ' ' VAL . 60.5 mt -78.11 44.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.386 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 38' ' ' THR . 19.5 t -38.48 -50.55 1.55 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.535 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.2 175.85 6.43 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.433 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -152.08 144.7 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.453 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -132.91 95.37 3.55 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.022 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 4' ' ' ILE . 14.2 t -116.92 110.76 41.46 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.59 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -70.67 168.61 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.204 1.269 . . . . 0.0 110.938 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HG3' HH11 ' A' ' 92' ' ' ARG . 1.7 Cg_endo -62.74 -178.38 0.39 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.055 1.837 . . . . 0.0 111.243 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.64 -21.22 9.43 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.252 -1.451 . . . . 0.0 110.995 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 2' ' ' ALA . 35.1 m -145.93 133.53 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.446 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.3 ttpt -102.44 136.93 41.38 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.906 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.09 150.38 34.13 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.979 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.05 114.35 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.6 mp -90.01 155.75 18.88 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.492 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 27.4 m-85 -138.08 112.02 8.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 49.7 tt0 -45.99 -84.55 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.512 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -59.92 146.03 43.75 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.038 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -177.16 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.627 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' C ' ' CD2' ' A' ' 58' ' ' PHE . . . 57.01 27.24 56.9 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.354 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' CZ ' HG23 ' A' ' 25' ' ' THR . 2.7 m-85 56.52 57.34 4.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -136.94 179.08 6.59 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.64 175.68 35.12 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.283 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 125.02 4.03 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.523 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -109.1 150.72 27.41 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.521 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 75' ' ' LEU . 2.0 mt -125.08 163.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -141.91 131.39 23.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.57 162.69 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -141.12 -12.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.595 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -117.74 -156.66 0.64 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.477 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.584 HD21 ' H ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -93.7 116.29 28.77 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.019 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.49 116.11 27.42 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -73.8 -75.76 0.14 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.663 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -9.87 59.18 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.538 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp 66.74 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.385 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.5 -178.45 47.1 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.503 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.44 -35.04 11.3 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.214 1.943 . . . . 0.0 112.219 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -77.54 15.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.225 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -65.93 -2.34 3.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -84.9 4.11 34.93 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.106 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -170.32 122.43 0.65 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 39' ' ' ILE . 1.5 t -147.34 160.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.27 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.427 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.42 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.5 m -101.61 138.51 38.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.386 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -146.12 160.37 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.921 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.16 119.23 6.72 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' H ' HH22 ' A' ' 83' ' ' ARG . 4.0 t -123.67 137.59 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.526 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.559 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.7 mt -135.11 128.95 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.534 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.79 136.42 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.299 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.75 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -133.46 148.78 70.21 Favored Pre-proline 0 N--CA 1.488 1.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.782 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.75 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -54.54 139.84 75.33 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.401 1.401 . . . . 0.0 111.44 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 133.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.491 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -137.6 153.32 74.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.437 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.2 Cg_endo -59.36 -162.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.927 1.085 . . . . 0.0 110.597 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 2.2 ptt180 -177.57 -161.64 0.06 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.583 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -135.03 176.04 9.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.924 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.607 ' NE ' ' OE1' ' A' ' 105' ' ' GLU . 5.8 ttm180 -147.12 128.08 14.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.361 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 128' ' ' ILE . 9.1 m-85 -116.24 133.17 56.32 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.33 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -90.15 -179.23 5.61 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.54 -80.77 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 4.9 mtpt -59.74 149.8 29.81 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.266 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.594 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 79.5 tt0 -69.67 94.8 0.82 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.747 ' NE2' ' HE1' ' A' ' 101' ' ' PHE . 8.7 tp60 134.19 49.73 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.102 1.501 . . . . 0.0 108.506 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.747 ' HE1' ' NE2' ' A' ' 100' ' ' GLN . 10.8 p90 32.25 32.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.563 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' GLN . 28.7 t0 -110.49 38.44 2.46 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -154.6 151.26 22.94 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.185 -1.484 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 103' ' ' GLY . 4.5 mttm -32.95 139.75 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.347 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE1' ' NE ' ' A' ' 94' ' ' ARG . 2.1 pt-20 -104.44 159.99 15.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.269 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -139.12 133.99 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.151 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.584 ' H ' HD21 ' A' ' 68' ' ' ASN . 45.1 p-10 -103.15 155.42 18.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 108' ' ' LEU . 67.8 mt -145.77 122.35 5.95 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.18 166.82 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.41 1.407 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.97 150.82 61.71 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.116 1.877 . . . . 0.0 111.882 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.53 -175.68 20.34 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.63 -1.272 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.548 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.1 tt0 -109.29 156.39 20.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.334 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.6 m-85 -143.37 152.25 41.39 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.775 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.62 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -93.04 -148.79 0.25 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.879 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.62 ' N ' ' OG1' ' A' ' 114' ' ' THR . 6.2 tt0 -108.49 -2.81 18.67 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.61 -62.47 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.975 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 7.5 pt-20 -66.98 -51.85 50.05 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.715 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.56 ' CD2' ' C ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -34.49 -70.74 0.07 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.925 0.766 . . . . 0.0 110.804 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -49.05 -61.51 2.03 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 2.5 mpt_? -75.79 20.7 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.13 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.9 t80 -121.97 -15.61 7.77 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.499 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -149.73 -41.18 0.03 OUTLIER Glycine 0 N--CA 1.484 1.871 0 C-N-CA 118.75 -1.69 . . . . 0.0 110.792 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.579 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.15 -106.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.781 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.476 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 3.4 t70 -172.36 -158.78 0.12 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.13 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.107 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.645 ' C ' HG22 ' A' ' 127' ' ' THR . 2.0 m-20 -115.8 117.85 31.37 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.418 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER 173.97 -0.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.7 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 95' ' ' PHE . 7.4 mt -67.95 -82.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.804 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 76.35 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.866 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.5 m -38.54 128.98 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.112 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 132' ' ' LYS . 8.9 t -120.97 158.73 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.477 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.414 ' N ' HG12 ' A' ' 131' ' ' VAL . 4.1 tttp -157.98 97.62 1.87 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.007 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.59 123.04 10.3 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 120.898 1.066 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.508 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -81.29 -1.71 46.16 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.091 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.23 -46.74 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.065 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -99.15 178.81 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.82 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.32 137.98 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.956 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.12 145.39 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.984 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' A' ' 141' ' ' PHE . 89.9 t -134.13 121.23 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.617 HD23 ' OG1' ' A' ' 167' ' ' THR . 11.2 mp -99.91 140.32 34.31 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.958 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.527 ' CE1' HG12 ' A' ' 139' ' ' VAL . 25.1 m-85 -118.63 128.88 54.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.523 ' CG ' HD22 ' A' ' 164' ' ' ASN . 9.5 tttm -63.03 -76.99 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.161 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -56.92 -178.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 146' ' ' PHE . 7.6 m-20 -64.47 -144.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.586 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -13.37 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 124.574 1.171 . . . . 0.0 113.518 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.5 OUTLIER 31.76 64.5 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.969 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 t -135.42 174.59 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.64 -163.45 53.36 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.28 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.75 165.3 3.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.2 p -148.0 156.45 42.66 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.599 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 151' ' ' LEU . 2.5 tt -125.8 78.92 68.98 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.753 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.58 103.26 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.985 1.79 . . . . 0.0 112.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.0 83.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 19.99 1.82 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.646 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 10.7 t -170.39 -178.12 2.63 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.683 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.63 ' N ' ' OG ' ' A' ' 155' ' ' SER . 44.2 m-20 -60.83 145.19 50.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -157.21 63.99 3.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.071 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -65.56 23.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.155 1.903 . . . . 0.0 112.434 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.0 96.57 0.28 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.842 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 161' ' ' GLY . 1.2 mt -123.79 -53.62 1.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.335 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . 35.88 -120.0 0.49 Allowed Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.14 101.07 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.611 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -142.08 -68.38 0.37 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.677 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.523 HD22 ' CG ' ' A' ' 142' ' ' LYS . 53.6 t-20 -91.34 -108.45 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.376 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 166' ' ' ASN . 1.8 m120 -153.63 -43.25 0.09 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 165' ' ' ASN . 0.8 OUTLIER -179.16 95.42 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.647 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.617 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -50.29 116.68 1.98 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 15.0 m -95.84 -61.97 1.36 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.8 161.3 18.38 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 118' ' ' LEU . 34.7 pt -144.79 174.64 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.177 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -158.69 112.62 2.43 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.024 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 172' ' ' ILE . 11.6 mt -88.36 103.41 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.773 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.818 0.342 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.596 ' CB ' HG11 ' A' ' 48' ' ' VAL . . . -149.43 172.86 14.26 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.992 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 1.6 p30 179.96 123.71 0.07 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.72 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 HG22 ' A' ' 44' ' ' VAL . 6.7 pt -74.49 141.28 16.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.334 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 m -120.25 112.85 19.57 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.781 ' HB ' HG23 ' A' ' 39' ' ' ILE . 2.5 m -91.2 174.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.557 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 1.106 ' CE2' ' NE2' ' A' ' 16' ' ' GLN . 48.5 m-85 -133.91 147.1 51.06 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.505 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.19 -37.5 61.16 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.567 ' H ' ' HA3' ' A' ' 14' ' ' GLY . 35.3 m120 -107.54 162.72 13.69 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.316 -0.953 . . . . 0.0 111.639 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.3 mt-10 -72.07 169.51 15.87 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.577 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 10' ' ' GLU . 1.5 t0 70.97 34.02 1.98 Allowed 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.989 -1.084 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER 60.5 -2.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 14' ' ' GLY . 8.4 tt0 -88.53 174.51 8.05 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.041 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.567 ' HA3' ' H ' ' A' ' 9' ' ' ASN . . . 91.06 137.4 7.25 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' GLY . 2.7 mttp -33.29 143.09 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.641 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 1.106 ' NE2' ' CE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -115.55 168.86 9.63 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.776 -0.77 . . . . 0.0 112.44 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.86 132.59 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.398 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.575 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -93.7 125.96 38.6 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.286 -0.966 . . . . 0.0 111.239 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 mt -121.38 126.95 26.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.333 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -63.76 158.62 45.63 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.938 1.092 . . . . 0.0 111.017 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.65 -167.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.739 1.626 . . . . 0.0 111.309 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' C ' ' NH2' ' A' ' 83' ' ' ARG . . . 96.49 173.85 35.38 Favored Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.42 -1.372 . . . . 0.0 110.78 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.857 ' H ' HD22 ' A' ' 23' ' ' ASN . 0.2 OUTLIER -106.3 128.6 54.1 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.834 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 24' ' ' TYR . 5.2 p90 -146.38 177.45 9.01 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.532 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 6.4 p -139.93 -160.95 1.13 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.648 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.2 -20.53 59.1 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.444 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.63 -63.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.776 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 6.4 tp60 -56.26 -45.03 80.24 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.817 -1.153 . . . . 0.0 109.674 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.778 HD22 HG23 ' A' ' 34' ' ' ILE . 12.4 mt -56.22 -41.44 75.65 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.826 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.21 53.54 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.942 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 28' ' ' GLN . . . -67.53 -38.04 83.62 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.935 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD12 HD23 ' A' ' 29' ' ' LEU . 8.8 mt -75.11 -73.29 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.451 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.51 -35.24 0.51 Allowed Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.873 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.778 HG23 HD22 ' A' ' 29' ' ' LEU . 1.7 tt -80.44 142.57 13.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.051 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.22 165.62 9.0 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.686 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.0 m120 62.87 -137.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 123.608 0.567 . . . . 0.0 111.602 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.905 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -80.38 98.48 7.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.702 -0.799 . . . . 0.0 113.012 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 40' ' ' SER . 3.4 p -154.69 -24.54 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.474 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 6' ' ' VAL . 60.5 mt -78.11 44.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.386 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 38' ' ' THR . 19.5 t -38.48 -50.55 1.55 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.535 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.2 175.85 6.43 Favored 'General case' 0 N--CA 1.507 2.385 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.433 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -152.08 144.7 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.453 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 tttp -132.91 95.37 3.55 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.022 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 4' ' ' ILE . 14.2 t -116.92 110.76 41.46 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.59 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -70.67 168.61 22.24 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 121.204 1.269 . . . . 0.0 110.938 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' HG3' HH11 ' A' ' 92' ' ' ARG . 1.7 Cg_endo -62.74 -178.38 0.39 Allowed 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.055 1.837 . . . . 0.0 111.243 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.64 -21.22 9.43 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.252 -1.451 . . . . 0.0 110.995 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.596 HG11 ' CB ' ' A' ' 2' ' ' ALA . 35.1 m -145.93 133.53 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.446 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 84' ' ' VAL . 22.3 ttpt -102.44 136.93 41.38 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.921 -0.711 . . . . 0.0 109.906 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.09 150.38 34.13 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.738 -0.785 . . . . 0.0 111.979 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -137.05 114.35 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.402 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HA ' HG23 ' A' ' 82' ' ' ILE . 2.6 mp -90.01 155.75 18.88 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.492 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 27.4 m-85 -138.08 112.02 8.41 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 55' ' ' ASN . 7.4 tt0 -45.99 -84.55 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.512 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -59.92 146.03 43.75 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.038 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.02 -177.16 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.627 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' C ' ' CD2' ' A' ' 58' ' ' PHE . . . 57.01 27.24 56.9 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.292 -1.432 . . . . 0.0 110.354 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' CZ ' HG23 ' A' ' 25' ' ' THR . 2.7 m-85 56.52 57.34 4.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.957 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 55' ' ' ASN . . . -136.94 179.08 6.59 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.64 175.68 35.12 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.283 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 125.02 4.03 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.523 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . 3.2 pt20 -109.1 150.72 27.41 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.521 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 75' ' ' LEU . 2.0 mt -125.08 163.99 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -141.91 131.39 23.81 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.908 -0.717 . . . . 0.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.57 162.69 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.0 t -141.12 -12.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.595 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.614 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . . . -117.74 -156.66 0.64 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.477 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.584 HD21 ' H ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -93.7 116.29 28.77 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.019 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.512 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -89.49 116.11 27.42 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.169 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -73.8 -75.76 0.14 Allowed 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.663 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.12 -9.87 59.18 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.538 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 tp 66.74 -81.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.385 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.5 -178.45 47.1 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.228 -1.463 . . . . 0.0 110.503 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -70.44 -35.04 11.3 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.214 1.943 . . . . 0.0 112.219 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.964 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.7 pt? -77.54 15.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.225 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -65.93 -2.34 3.84 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.459 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -84.9 4.11 34.93 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.106 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -170.32 122.43 0.65 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.153 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 39' ' ' ILE . 1.5 t -147.34 160.18 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.27 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.427 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.42 ' CB ' ' H ' ' A' ' 58' ' ' PHE . 3.5 m -101.61 138.51 38.51 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.386 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -146.12 160.37 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.921 HH22 ' H ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -150.16 119.23 6.72 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' H ' HH22 ' A' ' 83' ' ' ARG . 4.0 t -123.67 137.59 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.526 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.559 ' CG1' ' NH1' ' A' ' 83' ' ' ARG . 2.7 mt -135.11 128.95 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.534 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.79 136.42 1.99 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.299 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.75 HG22 ' HD2' ' A' ' 88' ' ' PRO . 0.4 OUTLIER -133.46 148.78 70.21 Favored Pre-proline 0 N--CA 1.488 1.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.782 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.75 ' HD2' HG22 ' A' ' 87' ' ' VAL . 5.4 Cg_exo -54.54 139.84 75.33 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.401 1.401 . . . . 0.0 111.44 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 133.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.491 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -137.6 153.32 74.14 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.437 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' C ' HD11 ' A' ' 136' ' ' LEU . 1.2 Cg_endo -59.36 -162.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.927 1.085 . . . . 0.0 110.597 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' N ' ' CD1' ' A' ' 136' ' ' LEU . 2.2 ptt180 -177.57 -161.64 0.06 Allowed 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.583 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.508 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -135.03 176.04 9.03 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.924 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.607 ' NE ' ' OE1' ' A' ' 105' ' ' GLU . 5.8 ttm180 -147.12 128.08 14.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.361 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 128' ' ' ILE . 9.1 m-85 -116.24 133.17 56.32 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.33 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.516 ' CG ' ' HA ' ' A' ' 101' ' ' PHE . 31.3 m-85 -90.15 -179.23 5.61 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.478 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.54 -80.77 0.49 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.14 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' H ' ' HA3' ' A' ' 103' ' ' GLY . 4.9 mtpt -59.74 149.8 29.81 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.266 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.594 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 79.5 tt0 -69.67 94.8 0.82 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.845 HE21 ' HA ' ' A' ' 100' ' ' GLN . 0.4 OUTLIER 134.19 49.73 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.043 0 O-C-N 125.102 1.501 . . . . 0.0 108.506 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' HE1' ' OE1' ' A' ' 100' ' ' GLN . 10.8 p90 32.25 32.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.563 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 100' ' ' GLN . 28.7 t0 -110.49 38.44 2.46 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.266 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 98' ' ' LYS . . . -154.6 151.26 22.94 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.185 -1.484 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 103' ' ' GLY . 4.5 mttm -32.95 139.75 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.347 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.607 ' OE1' ' NE ' ' A' ' 94' ' ' ARG . 2.1 pt-20 -104.44 159.99 15.28 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.269 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG21 ' O ' ' A' ' 122' ' ' GLY . 1.7 t -139.12 133.99 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.151 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.584 ' H ' HD21 ' A' ' 68' ' ' ASN . 45.1 p-10 -103.15 155.42 18.43 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.157 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 108' ' ' LEU . 67.8 mt -145.77 122.35 5.95 Favored Pre-proline 0 N--CA 1.483 1.205 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.614 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 1.6 Cg_endo -65.18 166.82 17.81 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 121.41 1.407 . . . . 0.0 111.674 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.97 150.82 61.71 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.116 1.877 . . . . 0.0 111.882 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.53 -175.68 20.34 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 119.63 -1.272 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.548 ' C ' ' CD1' ' A' ' 113' ' ' TYR . 2.1 tt0 -109.29 156.39 20.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.334 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.548 ' CD1' ' C ' ' A' ' 112' ' ' GLN . 24.6 m-85 -143.37 152.25 41.39 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.775 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.62 ' OG1' ' N ' ' A' ' 115' ' ' GLN . 0.6 OUTLIER -93.04 -148.79 0.25 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.879 -179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.62 ' N ' ' OG1' ' A' ' 114' ' ' THR . 6.2 tt0 -108.49 -2.81 18.67 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.964 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.61 -62.47 1.23 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.975 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' CG ' ' N ' ' A' ' 118' ' ' LEU . 7.5 pt-20 -66.98 -51.85 50.05 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.715 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.56 ' C ' ' CD2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -34.49 -70.74 0.07 Allowed 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.925 0.766 . . . . 0.0 110.804 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.476 ' HB3' ' C ' ' A' ' 124' ' ' ASP . 0.8 OUTLIER -49.05 -61.51 2.03 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 120' ' ' ARG . 2.5 mpt_? -75.79 20.7 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.212 -0.995 . . . . 0.0 112.13 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 117' ' ' GLU . 12.9 t80 -121.97 -15.61 7.77 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.499 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.781 ' O ' HG21 ' A' ' 106' ' ' VAL . . . -149.73 -41.18 0.03 OUTLIER Glycine 0 N--CA 1.484 1.871 0 C-N-CA 118.75 -1.69 . . . . 0.0 110.792 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -139.15 -106.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.781 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.476 ' C ' ' HB3' ' A' ' 119' ' ' GLU . 3.4 t70 -172.36 -158.78 0.12 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.506 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.13 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.107 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.645 ' C ' HG22 ' A' ' 127' ' ' THR . 2.0 m-20 -115.8 117.85 31.37 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.418 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.645 HG22 ' C ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER 173.97 -0.87 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.7 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 95' ' ' PHE . 7.4 mt -67.95 -82.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.804 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER 76.35 -136.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.866 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.5 m -38.54 128.98 1.45 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.112 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 132' ' ' LYS . 8.9 t -120.97 158.73 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.477 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.414 ' N ' HG12 ' A' ' 131' ' ' VAL . 4.1 tttp -157.98 97.62 1.87 Allowed Pre-proline 0 C--N 1.298 -1.667 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.007 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.59 123.04 10.3 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 120.898 1.066 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.508 ' H ' ' HA ' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -81.29 -1.71 46.16 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.091 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -176.23 -46.74 0.06 OUTLIER Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.262 -1.923 . . . . 0.0 112.065 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -99.15 178.81 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.085 -1.046 . . . . 0.0 110.82 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.32 137.98 36.25 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.956 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.12 145.39 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.984 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' A' ' 141' ' ' PHE . 89.9 t -134.13 121.23 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.007 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.617 HD23 ' OG1' ' A' ' 167' ' ' THR . 11.2 mp -99.91 140.32 34.31 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.958 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.527 ' CE1' HG12 ' A' ' 139' ' ' VAL . 25.1 m-85 -118.63 128.88 54.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.698 ' CE ' HD21 ' A' ' 164' ' ' ASN . 9.5 tttm -63.03 -76.99 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.161 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.92 -178.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.587 ' O ' ' N ' ' A' ' 146' ' ' PHE . 7.6 m-20 -64.47 -144.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.966 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.586 ' C ' ' CD1' ' A' ' 146' ' ' PHE . 0.1 OUTLIER -13.37 73.81 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 O-C-N 124.574 1.171 . . . . 0.0 113.518 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.5 OUTLIER 31.76 64.5 0.21 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.969 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 t -135.42 174.59 10.44 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.71 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.64 -163.45 53.36 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.28 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.75 165.3 3.15 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.2 p -148.0 156.45 42.66 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.028 -1.069 . . . . 0.0 111.599 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 151' ' ' LEU . 2.5 tt -125.8 78.92 68.98 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.753 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.58 103.26 0.26 Allowed 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.985 1.79 . . . . 0.0 112.505 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -87.0 83.28 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.053 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.51 19.99 1.82 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.646 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 156' ' ' ASP . 10.7 t -170.39 -178.12 2.63 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.683 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.63 ' N ' ' OG ' ' A' ' 155' ' ' SER . 44.2 m-20 -60.83 145.19 50.87 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 158' ' ' PRO . . . -157.21 63.99 3.14 Favored Pre-proline 0 C--N 1.307 -1.258 0 C-N-CA 119.899 -0.721 . . . . 0.0 110.071 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 157' ' ' ALA . 1.3 Cg_endo -65.56 23.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.155 1.903 . . . . 0.0 112.434 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -170.0 96.57 0.28 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.41 -1.316 . . . . 0.0 111.842 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 161' ' ' GLY . 1.2 mt -123.79 -53.62 1.76 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.335 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 160' ' ' LEU . . . 35.88 -120.0 0.49 Allowed Glycine 0 N--CA 1.497 2.73 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.14 101.07 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.466 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.611 ' C ' ' SD ' ' A' ' 163' ' ' MET . 0.2 OUTLIER -142.08 -68.38 0.37 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.677 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.746 HD22 ' C ' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -91.34 -108.45 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.376 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.591 ' N ' HD22 ' A' ' 164' ' ' ASN . 1.8 m120 -153.63 -43.25 0.09 Allowed 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 165' ' ' ASN . 0.8 OUTLIER -179.16 95.42 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.647 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.617 ' OG1' HD23 ' A' ' 140' ' ' LEU . 1.2 m -50.29 116.68 1.98 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.182 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 15.0 m -95.84 -61.97 1.36 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.209 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.8 161.3 18.38 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 118' ' ' LEU . 34.7 pt -144.79 174.64 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.177 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -158.69 112.62 2.43 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.024 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 172' ' ' ILE . 11.6 mt -88.36 103.41 13.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.302 -1.478 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.773 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_